What you actually get on Monday.
One email, one territory, written by a person. This is a real one, built from real filings.
This is a real sheet built from real filings. The companies, the amounts, the dates, the sectors, the people and the websites are all as filed, and every block links its filing on EDGAR so you can check it. Two lines are illustrative and marked like this: the phone number, because phone numbers never appear anywhere on this website, and the press check, because that one is done by hand for each send. In your sheet both are real.
Monday, your patch
4 companies, CaliforniaHi Dana,
4 new filings in your patch since last Monday. The ones worth your time, freshest first.
Filed July 23, 2026 to raise $22,883,644, with $14,283,643 of it sold so far. First sale July 15, 2026.
K-beauty growth and distribution partner that helps Korean skincare and cosmetics brands expand into the US retail and e-commerce market
Who to call: Sungman Chang, listed in the filing as an executive officer. LinkedIn search↗
Phone on the filing: (415) 555-0119 · Site: unlocktbrands.com↗
Nothing found on this raise as of Thursday.
Filed July 23, 2026 to raise $5,999,928, with $3,267,467 of it sold so far. First sale July 10, 2026.
Develops Amma, an FDA cleared portable scalp cooling system that helps chemotherapy patients prevent hair loss.
Who to call: Kathleen Dilligan, listed in the filing as an executive officer, director. LinkedIn search↗
Phone on the filing: (415) 555-0132 · Site: coolerheads.com↗
Nothing found on this raise as of Thursday.
Filed July 21, 2026 to raise $10,411,219, with $8,411,219 of it sold so far. First sale July 14, 2026.
Developer of a blood based diagnostic test using a proprietary pTau217 antibody to aid early detection of Alzheimer's disease.
Who to call: Michael Banville, listed in the filing as an executive officer, promoter. LinkedIn search↗
Phone on the filing: (415) 555-0148 · Site: alzpath.bio↗
Nothing found on this raise as of Thursday.
Filed July 20, 2026 to raise $6,292,026, with $5,586,503 of it sold so far. First sale July 6, 2026.
Clinical trial data platform specializing in continuous glucose and blood glucose monitoring device integration for pharma trials
Who to call: Jonathan Badgett, listed in the filing as an executive officer. LinkedIn search↗
Phone on the filing: (415) 555-0164 · Site: precisiondigitalhealth.com↗
Nothing found on this raise as of Thursday.
One number for context: in a study we ran on June filings, 22 of 30 of these raises still had no press six weeks after the money. The companies exist, the budgets exist, and mostly nobody is calling them.
Nick
What makes a sheet like this
One territory
You tell us the states you work or the sectors you place in when you start. A person reads that patch every week, which is why one subscription covers one territory and not the country.
Only what is worth a call
Most of what files is a fund, a property deal or a holding company, and most of the rest is not worth your Monday. What reaches the sheet is the handful that is, with the reason it made the cut visible in the facts.
Nothing invented
Every figure is the filer's own. No title is upgraded, no amount is rounded into a closed round, and where we have not verified a company's site or what it does, the line is simply absent rather than guessed.